AI is no longer a future concept; it’s a present-day driver of discovery and innovation in the life sciences industry.
In the first episode of Down the Gradient, Adine Mitrani and Toney Jacobson explore how AI is reshaping the industry with Andrew Whitehead, associate general counsel at Genentech.
The conversation examines the realities of securing meaningful patent protection for AI-related inventions, as well as the implications of revised inventorship guidance from the U.S. Patent and Trademark Office. Whitehead also shares insights on what makes an effective AI partnership, and the types of issues that can derail deals if left unaddressed.
Listen above or on: